Sign in
Robert A. Bradway
Photo: Amgen, Inc., CC BY-SA 4.0, via Wikimedia Commons33

Robert A. Bradway

American businessman (born 1962/63)

Robert A. Bradway (born 1962 or 1963) is an American businessman. He is the chairman and chief executive officer of Amgen.2

From Wikipedia’s article on Robert A. Bradway (this version), CC BY-SA 4.0.

Born 1963.1

Companies

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

  • Amgen AMGN535,100 shares14$231.4M at $432.40May 11, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

  • May 7, 2026Shares withheld for tax 2,079 shares at $331.11 of Amgen14
  • May 6, 2026Shares withheld for tax 1,702 shares at $329.59 of Amgen15
  • May 5, 2026Granted 12,136 shares of Amgen15
  • May 2, 2026Shares withheld for tax 2,426 shares at $329.82 of Amgen16
  • May 2, 2026Shares withheld for tax 2,631 shares at $329.82 of Amgen16
  • Mar 16, 2026Shares withheld for tax 21,294 shares at $366.21 of Amgen17
  • Mar 4, 2026Shares withheld for tax 84,285 shares at $379.27 of Amgen18
  • Mar 4, 2026Exercised options 119,782 shares at $156.35 of Amgen18
  • Mar 3, 2026Granted 42,657 shares of Amgen19
  • May 6, 2025Granted 13,311 shares of Amgen20
  • May 2, 2025Shares withheld for tax 2,352 shares at $283.78 of Amgen21
  • May 2, 2025Shares withheld for tax 2,481 shares at $283.78 of Amgen21
  • Apr 30, 2025Shares withheld for tax 2,544 shares at $288.56 of Amgen22
  • Mar 17, 2025Shares withheld for tax 12,853 shares at $313.71 of Amgen23
  • Mar 3, 2025Granted 25,734 shares of Amgen24
  • Dec 2, 2024Gift 90,000 shares of Amgen25
  • Dec 2, 2024Gift 90,000 shares of Amgen25
  • Dec 2, 2024Gift 96,000 shares of Amgen25
  • May 7, 2024Granted 11,988 shares of Amgen26
  • May 5, 2024Shares withheld for tax 2,220 shares at $311.29 of Amgen27
  • May 2, 2024Shares withheld for tax 2,294 shares at $277.37 of Amgen28
  • Apr 30, 2024Shares withheld for tax 2,282 shares at $276.38 of Amgen29
  • Mar 18, 2024Shares withheld for tax 20,560 shares at $268.87 of Amgen30
  • Mar 6, 2024Granted 41,133 shares of Amgen31
  • May 5, 2023Shares withheld for tax 2,083 shares at $231.89 of Amgen32

Early life and education

  • Date not recordedHarvard Business School3
  • Date not recordedHarvard University3
  • Date not recordedAmherst College3

Bradway holds a B.S. degree in biology from Amherst College and an M.B.A. from Harvard University.

From Wikipedia’s article on Robert A. Bradway (this version), CC BY-SA 4.0.

Career

Occupation: businessperson.6

Bradway joined Morgan Stanley in New York in 1985 as a health care industry investment banker. In 1990 he moved to London, where he was a managing director with responsibility for the firm's banking department and corporate finance activities in Europe.

Bradway joined Amgen in 2006 as vice president of operations strategy, and was executive vice president and chief financial officer from April 2007 to May 2010. He was its president and chief operating officer from May 2010 to May 2012. In October 2011, he was appointed to the Amgen board of directors. Bradway was named CEO of Amgen in May 2012, and chairman of the board in January 2013.

During Bradway’s tenure as CEO, Amgen's annual revenue increased from $17.3 billion in 2012 to $26 billion in 2021, and annual R&D investment increased to $4.2 billion in 2020. Bradway oversaw the acquisition of Iceland-based DeCODE Genetics in 2012, Onyx Pharmaceuticals in 2013, and a 20.5% equity stake in Beijing-based BeiGene in 2020.

Read more

Boards and volunteer activities

Bradway is on the board of directors of Boeing. He gave the 2016 commencement speech at the Keck Graduate Institute, which is part of The Claremont Colleges. He gave the 2017 commencement speech at the UCLA Anderson School of Management, where he is on the board of trustees and on the board of the Leonard D. Schaeffer Center for Health Policy and Economics.

He is the chairman of the CEO Roundtable on Cancer and a member of the American Heart Association CEO Roundtable.

Public statements

Bradway was a keynote speaker at the 2015 World Medical Innovation Forum. In June 2017, he gave the keynote address at the commencement ceremony for graduates of the University of California, Los Angeles Anderson School of Management. Bradway was a speaker at Fortune magazine's Brainstorm Health virtual conference in June 2020.

Following the 2020 murder of George Floyd in May 2020, Bradway issued a statement condemning the murder as "senseless" and pledging to address racial inequality at Amgen, stating, "Let's take inspiration from science and trust that progress, like knowledge, builds upon itself, incrementally improving on what exists today until the cumulative adds up to something profound."

On October 1, 2020, Bradway testified before the House Oversight Committee and was questioned by Rep. Katie Porter (D. Cal) for his considerable compensation. He and four other top Amgen executives earned a combined $124.2 million over a three-year period spanning 2017–2019.

From Wikipedia’s article on Robert A. Bradway (this version), CC BY-SA 4.0.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
    Wikidata and SEC EDGARBoeing, Board member
  8. 8
    SEC EDGARAmgen, Chair
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33